Trueblue, Inc. (TBI) is a publicly traded Industrials sector company. As of May 21, 2026, TBI trades at $5.44 with a market cap of $169.65M and a P/E ratio of -3.07. TBI moved +1.58% today. Year to date, TBI is +15.25%; over the trailing twelve months it is -3.55%. Its 52-week range spans $3.18 to $9.05. Analyst consensus is buy with an average price target of $5.50. Rallies surfaces TBI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading TBI stock inside the company?
Recent TBI insider activity includes Ferencz Garrett bought 7.00K, Owen Taryn R bought 20.40K, Schweihs Carl bought 12.50K, Schweihs Carl bought 2.50K, and Owen Taryn R bought 12.73K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
TBI Key Metrics
Key financial metrics for TBI
Metric
Value
Price
$5.44
Market Cap
$169.65M
P/E Ratio
-3.07
EPS
$-1.79
Dividend Yield
0.00%
52-Week High
$9.05
52-Week Low
$3.18
Volume
0
Avg Volume
0
Revenue (TTM)
$1.64B
Net Income
$-53.41M
Gross Margin
21.93%
Recent TBI Insider Trades
Ferencz Garrett bought 7.00K (~$25.27K) on Feb 25, 2026.
Owen Taryn R bought 20.40K (~$77.32K) on Feb 24, 2026.
Schweihs Carl bought 12.50K (~$46.50K) on Feb 23, 2026.
Schweihs Carl bought 2.50K (~$13.13K) on Mar 12, 2025.
Owen Taryn R bought 12.73K (~$75.65K) on Feb 26, 2025.
Recent TBI insider activity includes Ferencz Garrett bought 7.00K, Owen Taryn R bought 20.40K, Schweihs Carl bought 12.50K, Schweihs Carl bought 2.50K, and Owen Taryn R bought 12.73K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for TBI?
Yes. Rallies tracks TBI insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is TBI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for TBI. It does not provide personalized investment advice.
